Quick answer
Urolift is the prostatic urethral lift: small permanent implants hold the lobes of an enlarged prostate to the sides and open the way for urine, without removing tissue.1 The European guideline recommends it for prostates smaller than 70 g, with no middle lobe.1 In the L.I.F.T. study, the improvement lasted 5 years, no man developed lasting erectile or ejaculatory problems, and 13.6% needed another operation.4 I assess Urolift with each patient, together with Rezum, iTind, Greenlight, HoLEP and EchoLaser.
What Urolift is
In an enlarged prostate, the lobes grow inward and squeeze the urethra, the channel urine flows through. In Urolift, the urologist passes a cystoscope through the urethra and places small implants that cross the lobe and anchor on the outside of the prostate capsule. Each implant works like a tie-back: it pulls the lobe to the side and leaves the channel more open.1
Nothing is cut, burned or removed, and the implants stay in the body. The procedure can be done under local or general anesthesia.1 In the L.I.F.T. study, men returned to their usual physical activity in 8.6 days on average.4
Who the evidence supports it for
The European guideline gives a strong recommendation to Urolift for men with symptoms of an enlarged prostate, a prostate smaller than 70 g and no middle lobe.1 The L.I.F.T. study, which underpins the technique, included men aged 50 or over with prostates of 30 to 80 g.3 In practice, this has to be assessed case by case. According to the guideline, effectiveness in large prostates has not been shown.1
The middle lobe is the part of the prostate that grows into the bladder, right at the outlet. In the MedLift study, 45 men with an obstructive middle lobe had Urolift, and the symptom score (IPSS) fell by at least 13.5 points over 12 months.6 The study had no comparison group, and the European guideline considers the middle lobe data limited.1 In practice, this also has to be assessed case by case.
Men who care a lot about preserving ejaculation often ask about Urolift. It is one of the points in the choice, together with the size and shape of the prostate, the symptoms and the medications.
What the studies show
| Study | Patients | Result |
|---|---|---|
| L.I.F.T., 2013 | 206 men, Urolift or sham procedure | At 3 months, IPSS fell 11.1 points with Urolift and 5.9 with sham3 |
| L.I.F.T., 5 years | The same men, followed for 5 years | Symptoms 36% lower, quality of life 50% better and flow 44% higher; retreatment in 13.6%4 |
| BPH6, 2 years | 80 men, Urolift or TURP | Symptoms and flow improved more with TURP; recovery and ejaculation were better with Urolift5 |
| MedLift, 2019 | 45 men with a middle lobe | IPSS at least 13.5 points lower at 12 months, with no comparison group6 |
In BPH6, the first randomized trial against TURP, recovery and ejaculation preservation were better with Urolift.12 At 2 years, the fall in symptoms and the gain in flow were greater with TURP, and quality of life was similar in both groups.5 Relief tends to be smaller than with an operation that removes tissue, and that is part of the conversation before choosing.
How long it lasts and when another operation is needed
In L.I.F.T., 13.6% of men needed another operation within 5 years.4 Outside controlled studies, the numbers are a little higher. The European guideline cites a real-world analysis with 16.1% reintervention at 4 years, against 7.5% with TURP and 7.8% with photovaporization.1 In a United States database with more than 420,000 procedures, retreatment at 5 years was 16% with Urolift, 14% with Rezum, 7.1% with TURP and 4.4% with laser enucleation.9
For this reason, the European guideline advises telling patients that another operation is more common after Urolift than after TURP.1 In a review of 99 studies, the rate was 13.6% at 5 years, and the authors warn that 65% of the studies had a high risk of manufacturer influence.8
Ejaculation and erections
Preserving sexual function is the strong point of the technique. In L.I.F.T., sexual function was stable for 5 years, and no man developed lasting erectile or ejaculatory problems.4 In a review of 24 studies of minimally invasive treatments, loss of ejaculation was 0% with Urolift.7 What changes with each technique is in ejaculation and erections after each technique.
Risks
According to the European guideline, the most common complaints after Urolift are blood in the urine (16% to 63%), burning when urinating (25% to 58%), pelvic pain (5% to 17.9%), urgency (7.1% to 10%), temporary leakage (3.6% to 16%) and urinary infection (2.9% to 11%). In most men they are mild or moderate and settle within 2 to 4 weeks.1
After the procedure, see a urologist if you have a fever, difficulty urinating or blood with clots.
If symptoms come back
When symptoms return after a minimally invasive treatment, the first step is to find the cause. It may be prostate regrowth, an untreated middle lobe, or a narrowing of the urethra or bladder neck.11 In a review by the endourology section of the European Association of Urology, retreatment after Urolift ranged from 2% to 20%, and both repeating a minimally invasive treatment and having a traditional operation, such as TURP, were feasible.11 The choice depends on the cause and on what the patient wants to preserve. What to look into is in symptoms back after prostate surgery.
What the guidelines say
- European guideline (EAU, 2026): strong recommendation to offer Urolift to men with a prostate smaller than 70 g and no middle lobe, and weak recommendation to advise that another operation is more common than after TURP.1
- American guideline (AUA, 2026): includes the prostatic urethral lift among the procedures for an enlarged prostate and says that shared decision-making with the patient is essential to choose the technique.2
Cost and health plans
Many people look up the price of Urolift before a consultation. I do not publish prices on the site, because the cost changes from one case to another: it depends on the hospital, the number of implants, the anesthesia and what your plan authorizes. It is discussed individually, after the assessment. In my experience, Brazilian health plans have not authorized Urolift.
| Part | What it is |
|---|---|
| Hospital | The operating room and the anesthesia |
| Materials | The implants, which stay in the body, and the device that places them |
| Medical team | The surgeon and the team who perform the procedure |
The ANS, Brazil's health plan regulator, keeps the list of what Brazilian health plans are required to cover. In the current list, the prostate section includes TURP, laser photovaporization (the Greenlight technique), prostatectomy and other procedures, but no item under the name of the prostatic urethral lift.10 There is an old, generic item, "prostatic hypertrophy: prosthesis implant", and the list does not say whether it applies to Urolift implants.10 Each plan and contract has its own rules, so ask for authorization in advance and keep the answer in writing. If your plan says no, you can ask it to give the reason in writing.13 If you have insurance from outside Brazil, coverage depends on your policy, so ask your insurer before you travel.
How reimbursement works is in insurance and reimbursement, and the cost and coverage of every prostate operation is compared in prostate surgery cost.
Urolift, Rezum, iTind or HoLEP
| Technique | How it works | Loss of ejaculation | Retreatment |
|---|---|---|---|
| Urolift | Implants hold the lobes apart; nothing is removed | 0% | 13.6% at 5 years |
| Rezum | Water vapor treats the tissue, which the body absorbs | 3% | 11.1% at 5 years |
| iTind | Temporary device, removed after a few days | 1% | 11.1% at 4 years |
| HoLEP | The laser removes all the enlarged tissue | Almost never preserved | 4.4% at 5 years |
Loss of ejaculation for Urolift, Rezum and iTind comes from a review of 24 studies.7 Retreatment for those three comes from a review of 99 studies,8 and for HoLEP from real-world data on laser enucleation.9 The numbers come from different studies and time frames, not a head-to-head comparison. After HoLEP, retrograde ejaculation, in which semen goes into the bladder, is the rule.
In a study from Singapore, with 62 men who had Urolift and 86 who had Rezum, symptom improvement was similar. With Rezum, the catheter stayed longer and minor complications were more common; with Urolift, another operation was more frequent (8.1% against none).14 The details are in Rezum vs other minimally invasive treatments. Greenlight and EchoLaser are also part of the conversation: see Greenlight and EchoLaser.
How I approach it
Urolift is one of the options I assess with each patient, together with Rezum, iTind, Greenlight, HoLEP, EchoLaser and TURP. Before recommending any technique, I look at the size and shape of the prostate, whether there is a middle lobe, your symptoms, your medications and what you want to preserve. We make the decision together.
I was one of the pioneers of Rezum in Brazil, performing some of the first procedures in the country in July 2023, and I have performed Greenlight since 2019, with more than 500 procedures. I am a proctor for both techniques and guide colleagues from other states through their first cases. Proctoring explains how it works. The first consultation can be in person, at my office in Vila Mariana, or online, in English, with your tests sent in advance.
When to see a urologist
- If you have an enlarged prostate and medications do not bring enough relief
- If preserving ejaculation weighs on your decision
- If you want to know whether Urolift suits your case
- If you have had Urolift and your symptoms have come back
Send your case
If you would like to know, before a consultation, which technique makes sense for your prostate, fill in the form below. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.
Frequently asked questions
What is Urolift?+
It is the brand name of the prostatic urethral lift. Small permanent implants, placed through the urethra with a cystoscope, hold the lobes of the prostate to the sides and leave the urinary channel more open, without removing tissue. It can be done under local or general anesthesia.1
Who is Urolift for?+
The European guideline strongly recommends Urolift for men with a prostate smaller than 70 g and no middle lobe.1 The L.I.F.T. study included prostates of 30 to 80 g.3 In practice, this has to be assessed case by case.
Does Urolift work with a middle lobe?+
The data are limited. In the MedLift study, 45 men with an obstructive middle lobe had symptom improvement at 12 months, but the study had no comparison group.6 The European guideline recommends Urolift for prostates without a middle lobe.1
Does Urolift preserve ejaculation?+
In the studies, yes. In L.I.F.T., no man developed lasting erectile or ejaculatory problems over 5 years.4 In a review of 24 studies, loss of ejaculation was 0% with Urolift.7
How long do Urolift results last?+
In the L.I.F.T. study, symptom improvement lasted 5 years, and 13.6% of men needed another operation in that period.4 In real-world data from the United States, retreatment at 5 years was 16% with Urolift, against 7.1% with TURP.9
What are the risks of Urolift?+
The most common are blood in the urine, burning when urinating, pelvic pain, urgency, temporary leakage and urinary infection. In most men they are mild and settle within 2 to 4 weeks.1
How much does Urolift cost? Do Brazilian health plans cover it?+
I do not publish prices, because the cost changes from one case to another. The current ANS list, which sets what Brazilian health plans must cover, has no item under the name of the prostatic urethral lift.10 In my experience, Brazilian health plans have not authorized Urolift. Each plan and contract has its own rules, so ask for authorization in advance and keep the answer in writing. If you have insurance from outside Brazil, coverage depends on your policy.
Urolift, Rezum, iTind or HoLEP?+
The four work in different ways. In a review, loss of ejaculation was 0% with Urolift, 1% with iTind and 3% with Rezum.7 HoLEP removes all the enlarged tissue and almost never preserves ejaculation, but in real-world data retreatment at 5 years was 4.4% with laser enucleation.9 I assess all of them with you, together with Greenlight and EchoLaser.
Who can assess Urolift for me in Brazil?+
I am Dr. Petronio Melo, a urologist and robotic surgeon in São Paulo, CRM-SP 157.598 and RQE 70.275. I was one of the pioneers of Rezum in Brazil and I am a proctor for Rezum and for Greenlight, which I have performed since 2019, with more than 500 procedures. In the consultation, I assess Urolift alongside the other treatments for an enlarged prostate. My office is in Vila Mariana, and the first consultation can be in person or online, in English.
References
- EAU Guidelines on the Management of Non-neurogenic Male LUTS. European Association of Urology; 2026. Disease management chapter. EAU
- Goueli R, Badlani GH, Welliver C, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part III: Procedural/Surgical Management. J Urol. 2026;216(2):161-170. PubMed
- Roehrborn CG, Gange SN, Shore ND, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol. 2013;190(6):2161-7. PubMed
- Roehrborn CG, Barkin J, Gange SN, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017;24(3):8802-8813. PubMed
- Gratzke C, Barber N, Speakman MJ, et al. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int. 2017;119(5):767-775. PubMed
- Rukstalis D, Grier D, Stroup SP, et al. Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostatic Dis. 2019;22(3):411-419. PubMed
- Franco A, Ditonno F, Manfredi C, et al. Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction. Eur Urol. 2026;89(4):318-331. PubMed
- Akgul B, Tozsin A, Aydın A, et al. Reintervention rates after minimally invasive benign prostatic hyperplasia therapies: a systematic review including industry involvement. World J Urol. 2025;43(1):494. PubMed
- Carletti F, Tamborino F, Turcan A, et al. Five-year Retreatment and Medication Restart Rates Following Benign Prostate Hyperplasia Treatments: A Nationwide Real-world Analysis Using Epic Cosmos. Eur Urol Focus. 2026;12(3):383-392. PubMed
- Agência Nacional de Saúde Suplementar (ANS). Rol de Procedimentos e Eventos em Saúde. Annex I of Normative Resolution No. 465/2021 and its amendments (version updated by RN No. 682/2026). ANS
- Bogatova S, Morozov A, Gauhar V, et al. Management of clinical failure after minimally invasive surgical therapies (MIST) for BPH: repeat MIST versus resection, enucleation or ablation, a narrative review from EAU endourology. World J Urol. 2026;44(1):211. PubMed
- Sønksen J, Barber NJ, Speakman MJ, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68(4):643-52. PubMed
- Agência Nacional de Saúde Suplementar (ANS). Justificativa de negativa de cobertura por escrito (written explanation of a coverage denial). ANS
- Law YXT, Chen WJK, Shen L, et al. Convective Water Vapor Energy Ablation (Rezum) Versus Prostatic Urethral Lift (Urolift): A 2-Year Prospective Study. J Endourol. 2024;38(12):1387-1394. PubMed
Would you like to talk about your case?
In the consultation, I go over your tests and your priorities.
Book a consultation5.0186 Google reviews
